Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Journal of Medical Economics|June 5, 2009
Predicting time to nursing home placement based on activities of daily living scores--a modelling analysis using data on Alzheimer's disease patients receiving rivastigmine or donepezilHind T Hatoum, Simu K Thomas, Swu-Jane Lin, et al.
Gender Medicine|August 18, 2009
Effects of gender on response to treatment with rivastigmine in mild cognitive impairment: A post hoc statistical modeling approachSteven Ferris, Roger Lane, Nikolaos Sfikas, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 14, 2008
BuChE-K and APOE epsilon4 allele frequencies in Lewy body dementias, and influence of genotype and hyperhomocysteinemia on cognitive declineRoger Lane, Yunsheng He, Christopher Morris, et al.
Current Medical Research and Opinion|April 1, 2006
Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's diseaseRoger Bullock, Howard Bergman, Jacques Touchon, et al.
Psychopharmacology|August 10, 2025
Ascending single-dose study of the safety, pharmacokinetics, and pharmacodynamics of CSTI-500, a novel monoamine triple reuptake inhibitor, first-in-humanLieuwe Appel, Robert Risinger, Anders Wall, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 18, 2005
Long-term benefits of rivastigmine in dementia associated with Parkinson's disease: an active treatment extension studyWerner Poewe, Erik Wolters, Murat Emre, et al.
Current Alzheimer Research|February 10, 2009
Different cholinesterase inhibitor effects on CSF cholinesterases in Alzheimer patientsAgneta Nordberg, Taher Darreh-Shori, Elaine Peskind, et al.
Current Medical Research and Opinion|August 9, 2005
Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year periodRoger Bullock, Jacques Touchon, Howard Bergman, et al.
International Journal of Geriatric Psychiatry|March 30, 2007
Subthreshold depression in patients with Parkinson's disease and dementia--clinical and demographic correlatesUwe Ehrt, Kolbjørn Brønnick, Peter Paul De Deyn, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 9, 2006
Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's diseaseDavid Burn, Murat Emre, Ian McKeith, et al.
Pageof 4